Search research articles
Contact Us
Filters
Showing results (101-110 of 114) with videos related to
Page
of 12
Sort By:
Cancer
|
September 1, 1996
Pretherapeutic erythrocyte polyamine spermine levels discriminate high risk relapsing patients with M1 prostate carcinoma
B G Cipolla, J Ziade, J Y Bansard, et al.
Molecular Immunology
|
June 23, 1999
Molecular analysis of the combining site of a monoclonal antibody against spermine
N Bouillé, J Johnston, A Royou, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
January 15, 1985
Diagnostic value of erythrocyte-free polyamines and histaminemia in malignant hepatic tumors and in liver cirrhosis
J P Moulinoux, D Delamaire, B Beau, et al.
Anticancer Research
|
September 3, 1999
Polyamines in human breast cancer and its relations to classical prognostic features: clinical implications
J Leveque, J Y Bansard, E Watier, et al.
The Journal of Urology
|
March 1, 1994
Erythrocyte polyamines and prognosis in stage D2 prostatic carcinoma patients
B Cipolla, F Guille, J P Moulinoux, et al.
Life Sciences
|
January 1, 1990
Red blood cell polyamine level changes following heart transplantation in man
J P Moulinoux, V Quemener, J Ollitrault, et al.
Urology
|
March 29, 2000
Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma
N Rioux-Leclercq, B Turlin, J Bansard, et al.
Gastroenterologie Clinique Et Biologique
|
October 1, 1988
[Diffuse pseudopolyposis of the colon: developmental form or cicatricial of hemorrhagic rectocolitis?]
J F Bretagne, M P Ramée, A Moisan, et al.
Leukemia
|
January 1, 1997
Erythrocyte spermine levels: a prognostic parameter in childhood common acute lymphoblastic leukemia
C Bergeron, J Y Bansard, P Le Moine, et al.
European Journal of Biochemistry
|
January 15, 1997
Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5
L Meijer, A Borgne, O Mulner, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 114) with videos related to
Sort By:
Page
of 12
Cancer
|
September 1, 1996
Pretherapeutic erythrocyte polyamine spermine levels discriminate high risk relapsing patients with M1 prostate carcinoma
B G Cipolla, J Ziade, J Y Bansard, et al.
Molecular Immunology
|
June 23, 1999
Molecular analysis of the combining site of a monoclonal antibody against spermine
N Bouillé, J Johnston, A Royou, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
January 15, 1985
Diagnostic value of erythrocyte-free polyamines and histaminemia in malignant hepatic tumors and in liver cirrhosis
J P Moulinoux, D Delamaire, B Beau, et al.
Anticancer Research
|
September 3, 1999
Polyamines in human breast cancer and its relations to classical prognostic features: clinical implications
J Leveque, J Y Bansard, E Watier, et al.
The Journal of Urology
|
March 1, 1994
Erythrocyte polyamines and prognosis in stage D2 prostatic carcinoma patients
B Cipolla, F Guille, J P Moulinoux, et al.
Life Sciences
|
January 1, 1990
Red blood cell polyamine level changes following heart transplantation in man
J P Moulinoux, V Quemener, J Ollitrault, et al.
Urology
|
March 29, 2000
Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma
N Rioux-Leclercq, B Turlin, J Bansard, et al.
Gastroenterologie Clinique Et Biologique
|
October 1, 1988
[Diffuse pseudopolyposis of the colon: developmental form or cicatricial of hemorrhagic rectocolitis?]
J F Bretagne, M P Ramée, A Moisan, et al.
Leukemia
|
January 1, 1997
Erythrocyte spermine levels: a prognostic parameter in childhood common acute lymphoblastic leukemia
C Bergeron, J Y Bansard, P Le Moine, et al.
European Journal of Biochemistry
|
January 15, 1997
Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5
L Meijer, A Borgne, O Mulner, et al.
Page
of 12